CHEMICAL & BIOPHARMACEUTICAL LABORATORIES OF PATRAS S A has a total of 31 patent applications. It decreased the IP activity by 44.0%. Its first patent ever was published in 2010. It filed its patents most often in EPO (European Patent Office), Australia and United States. Its main competitors in its focus markets pharmaceuticals, biotechnology and environmental technology are CHEMICAL & BIOPHARMACEUTICAL LAB OF PATRAS S A, HYBIO PHARMACEUTICAL CO LTD and ALLOZYNE INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | EPO (European Patent Office) | 8 | |
#2 | Australia | 6 | |
#3 | United States | 5 | |
#4 | China | 3 | |
#5 | Brazil | 2 | |
#6 | Israel | 2 | |
#7 | WIPO (World Intellectual Property Organization) | 2 | |
#8 | Canada | 1 | |
#9 | Republic of Korea | 1 | |
#10 | New Zealand | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Environmental technology | |
#4 | Organic fine chemistry | |
#5 | Macromolecular chemistry and polymers |
# | Name | Total Patents |
---|---|---|
#1 | Gatos Dimitrios | 25 |
#2 | Barlos Kleomenis | 23 |
#3 | Vasileiou Zoi | 9 |
#4 | Anastasiou Alexandra | 7 |
#5 | Barlos Kostas | 7 |
#6 | Ziovas Michail | 6 |
#7 | Barlos Kostas K | 6 |
#8 | Barlos Konstantinos | 5 |
#9 | Barlos Kleomenis K | 4 |
#10 | Kleomenis Barlos | 2 |
Publication | Filing date | Title |
---|---|---|
US2020317721A1 | A process for preparing a glucagon-like peptide | |
US2019263881A1 | Proinsulin derivatives | |
EP3725801A2 | Amino diacids containing peptide modifiers | |
NZ631001A | Solid phase peptide synthesis of insulin using side chain anchored lysine | |
EP2437776A2 | Relaxin peptide synthesis |